secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalo Therapeutics, Inc. (AVTX)
CIK:        0001534120
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0001628280-25-029225
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalo Therapeutics posts updated investor presentation; content not disclosed in filing
--------------------------------------------------------------------------------

- Company posted updated investor presentation on its website on June 4, 2025.
- No specific financial or operational updates from the presentation were included in the filing.
- Investors are directed to the company's website for full content.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534120/000162828025029225/0001628280-25-029225-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534120/000162828025029225/avtx-20250604.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-029225

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer